Detalles de la búsqueda
1.
Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective phase II study.
Haematologica;
2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38546676
2.
High risk of anxiety and depression in caregivers of adult patients with epilepsy and its negative impact on patients' quality of life.
Epilepsy Behav;
90: 132-136, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30530135
3.
Denitrification Characteristics of the Low-Temperature Tolerant Denitrification Strain Achromobacter spiritinus HS2 and Its Application.
Microorganisms;
12(3)2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38543502
4.
Prevalence, clinical characteristics and treatment outcome of factor X deficiency in a consecutive cohort of primary light-chain amyloidosis.
Leuk Res;
120: 106917, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35849875
5.
Corrigendum to "Prevalence, clinical characteristics and treatment outcome of factor X deficiency in a consecutive cohort of primary light-chain amyloidosis" Leuk. Res. 120C (2022) 106917.
Leuk Res;
124: 107003, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36567140
6.
A retrospective study of ultrahigh-risk (Mayo 2004 stage IIIb) AL amyloidosis and identification of predictors related to extremely early death.
Leuk Lymphoma;
63(7): 1758-1761, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35105262
7.
In vitro study on role of Hsp70 expression in DNA damage of human embryonic lung cells exposed to Benzo[a]pyrene.
Biomed Environ Sci;
17(2): 144-52, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15386940
Resultados
1 -
7
de 7
1
Próxima >
>>